Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Transmission Electron Microscope

By Drug Discovery Trends Editor | July 18, 2008

FEI Company offers a high-throughput, cryo transmission electron microscope (TEM) that combines high-throughput sample handling with state-of-the-art electron optics.  It provides fully-automated three-dimensional data about biological molecules and macromolecular complexes.  Designed specifically for the needs of cellular and structural biologists, the all-new Titan Krios TEM enables visualization of intricate interactive mechanisms of individual proteins and molecular machines within the three-dimensional architecture of living cells.

The Titan Krios is ideal for advanced, high-resolution, dual-axis cryo electron tomography of frozen hydrated cells and cell organelles, single particle analysis and 2D electron crystallography.  Based on FEI’s industry-leading Titan platform, the Titan Krios delivers superb stability and imaging with the flexibility of selecting optimum acceleration voltages between 80 and 300 kV.  The Titan Krios also features robotic, contamination-free “auto-loading” of up to 12 frozen samples and 24×7 operation due to liquid nitrogen auto fill systems. Finally, its environmental instrument enclosure provides optimal thermal and acoustic shielding reducing installation and operating requirements.

FEI Company 


Filed Under: Drug Discovery

 

Related Articles Read More >

Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority
Portrait photo of Pfizer EVP and Medtronic board member Lidia Fonseca
Medtronic appoints Pfizer EVP as independent board director

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50